BDSI BioDelivery Sciences International Inc.

+0.05  (+1%)
Previous Close 4.3
Open 4.34
Price To Book 5.88
Market Cap 389,425,189
Shares 89,523,032
Volume 422,151
Short Ratio
Av. Daily Volume 1,063,983

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b data released December 13, 2016 - primary endpoints not met.
Clonidine gel
Painful diabetic neuropathy (PDN)
Approved June 6, 2014.
BEMA Buprenorphine/Naloxone (BNX) - BUNAVAIL
Opioid dependence
Approved October 26, 2015.
BEMA Buprenorphine

Latest News

  1. Edited Transcript of BDSI earnings conference call or presentation 8-Aug-19 8:30pm GMT
  2. BioDelivery Sciences International, Inc. (BDSI) Q2 2019 Earnings Call Transcript
  3. BioDelivery (BDSI) Earnings & Sales Beat Estimates in Q2
  4. BioDelivery Sciences Reports Strong Second Quarter 2019 Results and Raises Net Sales Expectations
  5. How Much Are BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Insiders Taking Off The Table?
  6. Will BioDelivery Sciences International (BDSI) Report Negative Earnings Next Week? What You Should Know
  7. BioDelivery Sciences to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019
  8. SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating BioDelivery Sciences International, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
  9. Why a career Triangle pharma executive is bringing a Georgia spin-out to the region
  10. 3 Small-Caps That Look Like Bargains at Current Trading Levels
  11. BioDelivery Sciences Announces Further Improved Insurance Coverage for BELBUCA®
  12. Perrigo Completes Ranir Acquisition, Raises '19 Guidance
  13. Top Ranked Momentum Stocks to Buy for July 3rd
  14. Amarin (AMRN) Issues Update on Q2 Sales, Raises '19 Guidance
  15. 18 Stocks Joining The Russell Indices
  16. featured highlights include: BioDelivery, Ciena, United States and Molina
  17. Focus on 4 Liquid Picks on the Top Rung for Robust Returns
  18. What Makes BioDelivery (BDSI) a New Strong Buy Stock
  19. BioDelivery Sciences Expands Upon Report from Pain Management Task Force
  20. The Zacks Analyst Blog Highlights: Middlesex Water, Atlantic Power, NexPoint Residential Trust, Illumina and BioDelivery Sciences International